Martin Shkreli Resigns As CEO As Turing Pharma "Wishes Him Well"

Mark Melin

Published onDecember 18, 2015

Updated on May 13, 2021

The hoodie-clad world of Martin Shkreli, escorted to court in handcuffs yesterday, continues to fall apart today as he announced he was stepping down as CEO of Turing Pharmaceuticals AG, the company he had co-founded.

Ron Tiles to replace Martin Shkreli

The embattled Shkreli, arrested by FBI agents for securities fraud, is charged with seven counts, including being accused of running hedge fund MSMB Capital Management like a Ponzi scheme. Turing announced that its founder and current chairman, Ron Tilles, would replace...

Login required to continue reading.

Setup a free account to get access to this article (no credit card required).

View Full Article

Already a member? Log in here

Mark Melin

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Martin Shkreli Resigns As CEO As Turing Pharma "Wishes Him Well"

Ron Tiles to replace Martin Shkreli

Login required to continue reading.

Get Your Business News